Evidence map›Paper›PMID 22582086›Full record

ArticleMental health and substance use : dual diagnosis2012

Differences in substance-related risk behavior between dual and triple diagnosed severely mentally ill adults.

Michelle Decoux Hampton, Linda Chafetz, Carmen Portillo

Abstract read
In one paragraph

Article in Mental health and substance use : dual diagnosis, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Michelle Decoux HamptonSchool of Nursing, Samuel Merritt University, 3100 Summit Street, Oakland, CA, USA.
Linda Chafetz
Carmen Portillo
Samuel Merritt University · USUnity Health System · USUniversity of California, San Francisco · US

Funding

HIV/AIDS NURSING CARE AND PREVENTIONT32NR007081 · NINR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DAWSON-ROSE, CAROL, VLAHOV, DAVID · 1995 to 2016
$3.8M
CLINICAL TRIAL OF WELLNESS TRAINING FOR THE MENTALLY ILLR01NR005350 · NINR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI CHAFETZ, LINDA · 2001 to 2004
$1.4M
NINR NIH HHS R01 NR005350NINR NIH HHS T32 NR007081
6 · The paper itself

Abstract

objectivesThe purpose of this study was to determine if differences exist between adults with dual and triple diagnoses with regard to substance-related risk behaviors.

methodsThis secondary analysis was a cross-sectional study. There were 252 subjects with dual and triple diagnoses recruited from residential crisis programs in San Francisco. Using descriptive and logistic regression analyses, subjects in the two groups were compared with regard to demographic data, types of substances, and routes of administration used in the previous 30 days to determine risk for exposure and/or transmission of HIV/HCV.

resultsWhen compared to the dual diagnosis group, subjects with triple diagnoses were four times more likely to have engaged in IDU (p=.001) and 2.6 times more likely to use amphetamines (p=.05). They also reported using more types of substances over the lifetime (p<.0001). But with regard to other risk behaviors such as alcohol use to intoxication and cocaine/crack use, there were no significant differences.

conclusionThough many substance-related risk behaviors occurred in both groups, adults with triple diagnoses were more likely to engage in IDU, amphetamine use, and to use more types of substances over the lifetime. This information has the potential to inform interventions that might prevent/reduce substance-related risk in this population.

Identifiers

PMID22582086
PMCPMC3347481
OpenAlexW2007799217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.